Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Atsuko Nakanishi, Ozeki"'
Autor:
Kenzui Taniue, Anzu Sugawara, Chao Zeng, Han Han, Xinyue Gao, Yuki Shimoura, Atsuko Nakanishi Ozeki, Rena Onoguchi-Mizutani, Masahide Seki, Yutaka Suzuki, Michiaki Hamada, Nobuyoshi Akimitsu
Publikováno v:
Nature Communications, Vol 15, Iss 1, Pp 1-13 (2024)
Abstract RNA surveillance systems degrade aberrant RNAs that result from defective transcriptional termination, splicing, and polyadenylation. Defective RNAs in the nucleus are recognized by RNA-binding proteins and MTR4, and are degraded by the RNA
Externí odkaz:
https://doaj.org/article/f9709f2ac81943469067156ce2a93e1d
Autor:
Ryota Imura, Atsuko Nakanishi Ozeki, Nanako Shida, Mika Kobayashi, Hiroyuki Ida, Youichiro Wada, Nobuyoshi Akimitsu, Yoshitaka Kumakura
Publikováno v:
Nuclear Medicine and Biology. :21-28
Autor:
Jaewoong, Jang, Yoshitaka, Kumakura, Katsuyoshi, Tatenuma, Atsuko Nakanishi, Ozeki, Youichiro, Wada, Nobuyoshi, Akimitsu, Akira, Tsuguchi, Hidetoshi, Kikunaga, Shogo, Higaki, Mitsuru, Uesaka
Publikováno v:
Nuclear medicine and biology.
Production ofThe two types of [The clinical applicability of linac-AC-derived [
Autor:
Ryota, Imura, Atsuko Nakanishi, Ozeki, Nanako, Shida, Mika, Kobayashi, Hiroyuki, Ida, Youichiro, Wada, Nobuyoshi, Akimitsu, Yoshitaka, Kumakura
Publikováno v:
Nuclear medicine and biology.
Novel diagnostic and therapeutic options are urgently needed for patients with metastatic castration-resistant prostate cancer (CRPC). PSMA-617 is one of the most promising ligands that bind to prostate specific membrane antigen (PSMA), the cell surf